{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "CD30 ligand oligomers and polypeptides", "item": "https://www.patentleaderboard.com/patent/6143869"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CD30 ligand oligomers and polypeptides

CD30 ligand oligomers and polypeptides

US Patent 6143869 · Granted Nov 7, 2000

Estimated economic value: $545,859,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

BCMA antigen binding proteins2019
BCMA Antigen binding proteins2019
Human CD30 ligand antigen binding proteins2018
Anti-interleukin-4 receptor antibodies2017
BCMA antigen binding proteins2016
Anti-interleukin-4 receptor antibodies2014
ULBP2 polypeptides2013
CD47 related compositions and methods for treating immunological diseases and di2013
Methods for identifying polypeptide targets and uses thereof for treating immuno2012
Methods of use of the TACI/TACI-L interaction2012
Process for the synthesis of morphinane compounds and intermediates thereof2012
DNA encoding a soluble fragment of TRAIL polypeptide2011